For almost 50 years, the fractionation of human plasma has been the sole possible source of a wide range of therapeutic proteins--such as coagulation factors, anticoagulants, immunoglobulins, and albumin--essential to the treatment of serious congenital or acquired bleeding or immunological diseases. In the last 20 years, the application of recombinant technologies to mammalian cell cultures has made possible--although with some limitations in productivity, costs, and immunogenic risks-
This report aims to provide a comprehensive presentation of the global market for Recombinant Plasma Proteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Plasma Proteins. This report contains market size and forecasts of Recombinant Plasma Proteins in global, including the following market information:
Global Recombinant Plasma Proteins Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Recombinant Plasma Proteins market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Chinese Hamster Ovary (CHO) Cell Line Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Recombinant Plasma Proteins include CSL Limited, Shire (Takeda Pharmaceutical Company Limited), Octapharma, Novo Nordisk, Bayer, Bioverativ Therapeutics, Inc. (Sanofi), Aptevo Therapeutics, Pharming Group and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Plasma Proteins companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Plasma Proteins Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Recombinant Plasma Proteins Market Segment Percentages, by Type, 2022 (%)
Chinese Hamster Ovary (CHO) Cell Line
Baby Hamster Kidney (BHK) Cell Line
Human Embryonic Kidney (HEK) Cell Line
Others
Global Recombinant Plasma Proteins Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Recombinant Plasma Proteins Market Segment Percentages, by Application, 2022 (%)
Hemophilia A
Hemophilia B
Von Willebrand Disease
Others
Global Recombinant Plasma Proteins Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Recombinant Plasma Proteins Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Plasma Proteins revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Recombinant Plasma Proteins revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
CSL Limited
Shire (Takeda Pharmaceutical Company Limited)
Octapharma
Novo Nordisk
Bayer
Bioverativ Therapeutics, Inc. (Sanofi)
Aptevo Therapeutics
Pharming Group
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Plasma Proteins, market overview.
Chapter 2: Global Recombinant Plasma Proteins market size in revenue.
Chapter 3: Detailed analysis of Recombinant Plasma Proteins company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Plasma Proteins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant Plasma Proteins Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Plasma Proteins Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Plasma Proteins Overall Market Size
2.1 Global Recombinant Plasma Proteins Market Size: 2022 VS 2032
2.2 Global Recombinant Plasma Proteins Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Recombinant Plasma Proteins Players in Global Market
3.2 Top Global Recombinant Plasma Proteins Companies Ranked by Revenue
3.3 Global Recombinant Plasma Proteins Revenue by Companies
3.4 Top 3 and Top 5 Recombinant Plasma Proteins Companies in Global Market, by Revenue in 2022
3.5 Global Companies Recombinant Plasma Proteins Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant Plasma Proteins Players in Global Market
3.6.1 List of Global Tier 1 Recombinant Plasma Proteins Companies
3.6.2 List of Global Tier 2 and Tier 3 Recombinant Plasma Proteins Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Plasma Proteins Market Size Markets, 2022 & 2032
4.1.2 Chinese Hamster Ovary (CHO) Cell Line
4.1.3 Baby Hamster Kidney (BHK) Cell Line
4.1.4 Human Embryonic Kidney (HEK) Cell Line
4.1.5 Others
4.2 By Type - Global Recombinant Plasma Proteins Revenue & Forecasts
4.2.1 By Type - Global Recombinant Plasma Proteins Revenue, 2018-2023
4.2.2 By Type - Global Recombinant Plasma Proteins Revenue, 2024-2032
4.2.3 By Type - Global Recombinant Plasma Proteins Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Plasma Proteins Market Size, 2022 & 2032
5.1.2 Hemophilia A
5.1.3 Hemophilia B
5.1.4 Von Willebrand Disease
5.1.5 Others
5.2 By Application - Global Recombinant Plasma Proteins Revenue & Forecasts
5.2.1 By Application - Global Recombinant Plasma Proteins Revenue, 2018-2023
5.2.2 By Application - Global Recombinant Plasma Proteins Revenue, 2024-2032
5.2.3 By Application - Global Recombinant Plasma Proteins Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Recombinant Plasma Proteins Market Size, 2022 & 2032
6.2 By Region - Global Recombinant Plasma Proteins Revenue & Forecasts
6.2.1 By Region - Global Recombinant Plasma Proteins Revenue, 2018-2023
6.2.2 By Region - Global Recombinant Plasma Proteins Revenue, 2024-2032
6.2.3 By Region - Global Recombinant Plasma Proteins Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Recombinant Plasma Proteins Revenue, 2018-2032
6.3.2 US Recombinant Plasma Proteins Market Size, 2018-2032
6.3.3 Canada Recombinant Plasma Proteins Market Size, 2018-2032
6.3.4 Mexico Recombinant Plasma Proteins Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Recombinant Plasma Proteins Revenue, 2018-2032
6.4.2 Germany Recombinant Plasma Proteins Market Size, 2018-2032
6.4.3 France Recombinant Plasma Proteins Market Size, 2018-2032
6.4.4 U.K. Recombinant Plasma Proteins Market Size, 2018-2032
6.4.5 Italy Recombinant Plasma Proteins Market Size, 2018-2032
6.4.6 Russia Recombinant Plasma Proteins Market Size, 2018-2032
6.4.7 Nordic Countries Recombinant Plasma Proteins Market Size, 2018-2032
6.4.8 Benelux Recombinant Plasma Proteins Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Recombinant Plasma Proteins Revenue, 2018-2032
6.5.2 China Recombinant Plasma Proteins Market Size, 2018-2032
6.5.3 Japan Recombinant Plasma Proteins Market Size, 2018-2032
6.5.4 South Korea Recombinant Plasma Proteins Market Size, 2018-2032
6.5.5 Southeast Asia Recombinant Plasma Proteins Market Size, 2018-2032
6.5.6 India Recombinant Plasma Proteins Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Recombinant Plasma Proteins Revenue, 2018-2032
6.6.2 Brazil Recombinant Plasma Proteins Market Size, 2018-2032
6.6.3 Argentina Recombinant Plasma Proteins Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Recombinant Plasma Proteins Revenue, 2018-2032
6.7.2 Turkey Recombinant Plasma Proteins Market Size, 2018-2032
6.7.3 Israel Recombinant Plasma Proteins Market Size, 2018-2032
6.7.4 Saudi Arabia Recombinant Plasma Proteins Market Size, 2018-2032
6.7.5 UAE Recombinant Plasma Proteins Market Size, 2018-2032
7 Recombinant Plasma Proteins Companies Profiles
7.1 CSL Limited
7.1.1 CSL Limited Company Summary
7.1.2 CSL Limited Business Overview
7.1.3 CSL Limited Recombinant Plasma Proteins Major Product Offerings
7.1.4 CSL Limited Recombinant Plasma Proteins Revenue in Global Market (2018-2023)
7.1.5 CSL Limited Key News & Latest Developments
7.2 Shire (Takeda Pharmaceutical Company Limited)
7.2.1 Shire (Takeda Pharmaceutical Company Limited) Company Summary
7.2.2 Shire (Takeda Pharmaceutical Company Limited) Business Overview
7.2.3 Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Major Product Offerings
7.2.4 Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Revenue in Global Market (2018-2023)
7.2.5 Shire (Takeda Pharmaceutical Company Limited) Key News & Latest Developments
7.3 Octapharma
7.3.1 Octapharma Company Summary
7.3.2 Octapharma Business Overview
7.3.3 Octapharma Recombinant Plasma Proteins Major Product Offerings
7.3.4 Octapharma Recombinant Plasma Proteins Revenue in Global Market (2018-2023)
7.3.5 Octapharma Key News & Latest Developments
7.4 Novo Nordisk
7.4.1 Novo Nordisk Company Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Recombinant Plasma Proteins Major Product Offerings
7.4.4 Novo Nordisk Recombinant Plasma Proteins Revenue in Global Market (2018-2023)
7.4.5 Novo Nordisk Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Recombinant Plasma Proteins Major Product Offerings
7.5.4 Bayer Recombinant Plasma Proteins Revenue in Global Market (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 Bioverativ Therapeutics, Inc. (Sanofi)
7.6.1 Bioverativ Therapeutics, Inc. (Sanofi) Company Summary
7.6.2 Bioverativ Therapeutics, Inc. (Sanofi) Business Overview
7.6.3 Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Major Product Offerings
7.6.4 Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Revenue in Global Market (2018-2023)
7.6.5 Bioverativ Therapeutics, Inc. (Sanofi) Key News & Latest Developments
7.7 Aptevo Therapeutics
7.7.1 Aptevo Therapeutics Company Summary
7.7.2 Aptevo Therapeutics Business Overview
7.7.3 Aptevo Therapeutics Recombinant Plasma Proteins Major Product Offerings
7.7.4 Aptevo Therapeutics Recombinant Plasma Proteins Revenue in Global Market (2018-2023)
7.7.5 Aptevo Therapeutics Key News & Latest Developments
7.8 Pharming Group
7.8.1 Pharming Group Company Summary
7.8.2 Pharming Group Business Overview
7.8.3 Pharming Group Recombinant Plasma Proteins Major Product Offerings
7.8.4 Pharming Group Recombinant Plasma Proteins Revenue in Global Market (2018-2023)
7.8.5 Pharming Group Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Recombinant Plasma Proteins Major Product Offerings
7.9.4 Pfizer Recombinant Plasma Proteins Revenue in Global Market (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Recombinant Plasma Proteins Market Opportunities & Trends in Global Market
Table 2. Recombinant Plasma Proteins Market Drivers in Global Market
Table 3. Recombinant Plasma Proteins Market Restraints in Global Market
Table 4. Key Players of Recombinant Plasma Proteins in Global Market
Table 5. Top Recombinant Plasma Proteins Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Recombinant Plasma Proteins Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Recombinant Plasma Proteins Revenue Share by Companies, 2018-2023
Table 8. Global Companies Recombinant Plasma Proteins Product Type
Table 9. List of Global Tier 1 Recombinant Plasma Proteins Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Plasma Proteins Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Recombinant Plasma Proteins Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Recombinant Plasma Proteins Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Recombinant Plasma Proteins Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Recombinant Plasma Proteins Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Recombinant Plasma Proteins Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Recombinant Plasma Proteins Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Recombinant Plasma Proteins Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Recombinant Plasma Proteins Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Recombinant Plasma Proteins Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Recombinant Plasma Proteins Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Recombinant Plasma Proteins Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Recombinant Plasma Proteins Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Recombinant Plasma Proteins Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Recombinant Plasma Proteins Revenue, (US$, Mn), 2024-2032
Table 30. CSL Limited Company Summary
Table 31. CSL Limited Recombinant Plasma Proteins Product Offerings
Table 32. CSL Limited Recombinant Plasma Proteins Revenue (US$, Mn) & (2018-2023)
Table 33. CSL Limited Key News & Latest Developments
Table 34. Shire (Takeda Pharmaceutical Company Limited) Company Summary
Table 35. Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Product Offerings
Table 36. Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Revenue (US$, Mn) & (2018-2023)
Table 37. Shire (Takeda Pharmaceutical Company Limited) Key News & Latest Developments
Table 38. Octapharma Company Summary
Table 39. Octapharma Recombinant Plasma Proteins Product Offerings
Table 40. Octapharma Recombinant Plasma Proteins Revenue (US$, Mn) & (2018-2023)
Table 41. Octapharma Key News & Latest Developments
Table 42. Novo Nordisk Company Summary
Table 43. Novo Nordisk Recombinant Plasma Proteins Product Offerings
Table 44. Novo Nordisk Recombinant Plasma Proteins Revenue (US$, Mn) & (2018-2023)
Table 45. Novo Nordisk Key News & Latest Developments
Table 46. Bayer Company Summary
Table 47. Bayer Recombinant Plasma Proteins Product Offerings
Table 48. Bayer Recombinant Plasma Proteins Revenue (US$, Mn) & (2018-2023)
Table 49. Bayer Key News & Latest Developments
Table 50. Bioverativ Therapeutics, Inc. (Sanofi) Company Summary
Table 51. Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Product Offerings
Table 52. Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Revenue (US$, Mn) & (2018-2023)
Table 53. Bioverativ Therapeutics, Inc. (Sanofi) Key News & Latest Developments
Table 54. Aptevo Therapeutics Company Summary
Table 55. Aptevo Therapeutics Recombinant Plasma Proteins Product Offerings
Table 56. Aptevo Therapeutics Recombinant Plasma Proteins Revenue (US$, Mn) & (2018-2023)
Table 57. Aptevo Therapeutics Key News & Latest Developments
Table 58. Pharming Group Company Summary
Table 59. Pharming Group Recombinant Plasma Proteins Product Offerings
Table 60. Pharming Group Recombinant Plasma Proteins Revenue (US$, Mn) & (2018-2023)
Table 61. Pharming Group Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Recombinant Plasma Proteins Product Offerings
Table 64. Pfizer Recombinant Plasma Proteins Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Key News & Latest Developments
List of Figures
Figure 1. Recombinant Plasma Proteins Segment by Type in 2022
Figure 2. Recombinant Plasma Proteins Segment by Application in 2022
Figure 3. Global Recombinant Plasma Proteins Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Plasma Proteins Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Recombinant Plasma Proteins Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Recombinant Plasma Proteins Revenue in 2022
Figure 8. By Type - Global Recombinant Plasma Proteins Revenue Market Share, 2018-2032
Figure 9. By Application - Global Recombinant Plasma Proteins Revenue Market Share, 2018-2032
Figure 10. By Type - Global Recombinant Plasma Proteins Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Recombinant Plasma Proteins Revenue Market Share, 2018-2032
Figure 12. By Application - Global Recombinant Plasma Proteins Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Recombinant Plasma Proteins Revenue Market Share, 2018-2032
Figure 14. By Region - Global Recombinant Plasma Proteins Revenue Market Share, 2018-2032
Figure 15. By Country - North America Recombinant Plasma Proteins Revenue Market Share, 2018-2032
Figure 16. US Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Recombinant Plasma Proteins Revenue Market Share, 2018-2032
Figure 20. Germany Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 21. France Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Recombinant Plasma Proteins Revenue Market Share, 2018-2032
Figure 28. China Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 32. India Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Recombinant Plasma Proteins Revenue Market Share, 2018-2032
Figure 34. Brazil Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Recombinant Plasma Proteins Revenue Market Share, 2018-2032
Figure 37. Turkey Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Recombinant Plasma Proteins Revenue, (US$, Mn), 2018-2032
Figure 41. CSL Limited Recombinant Plasma Proteins Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Octapharma Recombinant Plasma Proteins Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novo Nordisk Recombinant Plasma Proteins Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bayer Recombinant Plasma Proteins Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Aptevo Therapeutics Recombinant Plasma Proteins Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pharming Group Recombinant Plasma Proteins Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Recombinant Plasma Proteins Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
